Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena Buckstein

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Leukemia & Lymphoma|April 20, 2013
Granulocyte colony-stimulating factor as secondary prophylaxis of febrile neutropenia in the management of advanced-stage Hodgkin lymphoma treated with adriamycin, bleomycin, vinblastine and dacarbazine chemotherapy: a decision analysisJoanna Graczyk, Matthew C Cheung, Rena Buckstein, et al.
Blood Advances|November 29, 2023
A Markov analysis of azacitidine and venetoclax vs induction chemotherapy for medically fit patients with AMLMithunan Ravindran, Lee Mozessohn, Matthew Cheung, et al.
Hematology (Amsterdam, Netherlands)|December 21, 2006
Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case reportRena Buckstein, Harshna Patel, Alden Chesney, et al.
The Journal of Rheumatology|January 12, 2007
Macrophage activation syndrome after etanercept treatmentCharanjit Sandhu, Alden Chesney, Eugenia Piliotis, et al.
British Journal of Haematology|October 18, 2014
Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survivalAnna Nikonova, Hany R Guirguis, Rena Buckstein, et al.
Critical Reviews in Oncology/Hematology|August 21, 2012
The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: a clinical practice guidelineHeather A Leitch, Rena Buckstein, April Shamy, et al.
British Journal of Haematology|March 14, 2015
Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndromeEric Tseng, Raed Alhusayen, Shachar Sade, et al.
Leukemia & Lymphoma|May 17, 2016
Validation of the NCCN-IPI in both de novo and transformed diffuse large B cell lymphomaJay Y Spiegel, Matthew C Cheung, Hany R Guirguis, et al.
Experimental Hematology|December 3, 2017
An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesisSamuel O Abegunde, Rena Buckstein, Richard A Wells, et al.
Cancer|January 28, 2003
Treatment options for patients with acute myeloid leukemia with a matched sibling donor: a decision analysisLillian Sung, Rena Buckstein, John J Doyle, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|April 20, 2013
Granulocyte colony-stimulating factor as secondary prophylaxis of febrile neutropenia in the management of advanced-stage Hodgkin lymphoma treated with adriamycin, bleomycin, vinblastine and dacarbazine chemotherapy: a decision analysisJoanna Graczyk, Matthew C Cheung, Rena Buckstein, et al.
Blood Advances|November 29, 2023
A Markov analysis of azacitidine and venetoclax vs induction chemotherapy for medically fit patients with AMLMithunan Ravindran, Lee Mozessohn, Matthew Cheung, et al.
Hematology (Amsterdam, Netherlands)|December 21, 2006
Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case reportRena Buckstein, Harshna Patel, Alden Chesney, et al.
The Journal of Rheumatology|January 12, 2007
Macrophage activation syndrome after etanercept treatmentCharanjit Sandhu, Alden Chesney, Eugenia Piliotis, et al.
British Journal of Haematology|October 18, 2014
Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survivalAnna Nikonova, Hany R Guirguis, Rena Buckstein, et al.
Critical Reviews in Oncology/Hematology|August 21, 2012
The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: a clinical practice guidelineHeather A Leitch, Rena Buckstein, April Shamy, et al.
British Journal of Haematology|March 14, 2015
Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndromeEric Tseng, Raed Alhusayen, Shachar Sade, et al.
Leukemia & Lymphoma|May 17, 2016
Validation of the NCCN-IPI in both de novo and transformed diffuse large B cell lymphomaJay Y Spiegel, Matthew C Cheung, Hany R Guirguis, et al.
Experimental Hematology|December 3, 2017
An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesisSamuel O Abegunde, Rena Buckstein, Richard A Wells, et al.
Cancer|January 28, 2003
Treatment options for patients with acute myeloid leukemia with a matched sibling donor: a decision analysisLillian Sung, Rena Buckstein, John J Doyle, et al.
Pageof 14